Melanoma-Specific Antigens
"Melanoma-Specific Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cellular antigens that are specific for MELANOMA cells.
| Descriptor ID |
D058950
|
| MeSH Number(s) |
D12.776.624.301 D23.050.285.439
|
| Concept/Terms |
Melanoma-Specific Antigens- Melanoma-Specific Antigens
- Antigens, Melanoma-Specific
- Melanoma Specific Antigens
- Melanoma Antigens
- Antigens, Melanoma
|
Below are MeSH descriptors whose meaning is more general than "Melanoma-Specific Antigens".
Below are MeSH descriptors whose meaning is more specific than "Melanoma-Specific Antigens".
This graph shows the total number of publications written about "Melanoma-Specific Antigens" by people in this website by year, and whether "Melanoma-Specific Antigens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Melanoma-Specific Antigens" by people in Profiles.
-
Retroperitoneal PEComa related to the femoral nerve. J Neurosurg Sci. 2017 02; 61(1):109-112.
-
Atypical histopathologic features in a melanocytic nevus after cryotherapy and pregnancy. J Cutan Pathol. 2014 Oct; 41(10):802-5.
-
Kba.62 and S100 protein expression in cytologic samples of metastatic malignant melanoma. Diagn Cytopathol. 2013 Oct; 41(10):847-51.
-
BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma. Clin Cancer Res. 2013 Mar 01; 19(5):1225-31.
-
Aberrant expression of HMB-45 in traumatized melanocytic nevi. J Am Acad Dermatol. 2012 Sep; 67(3):446-50.
-
Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation. Eur J Cancer. 2012 Jan; 48(1):12-23.
-
Phase I study of decitabine with doxorubicin and cyclophosphamide in children with neuroblastoma and other solid tumors: a Children's Oncology Group study. Pediatr Blood Cancer. 2010 Oct; 55(4):629-38.
-
Expression of Sox-9 in metastatic melanoma--a potential diagnostic pitfall. Am J Dermatopathol. 2010 May; 32(3):262-266.
-
Cutaneous metastases of malignant melanoma: a clinicopathologic study of 192 cases with emphasis on the morphologic spectrum. Am J Dermatopathol. 2010 Apr; 32(2):129-36.
-
Nuclear to non-nuclear Pmel17/gp100 expression (HMB45 staining) as a discriminator between benign and malignant melanocytic lesions. Mod Pathol. 2008 Sep; 21(9):1121-9.